The Beckley/Maastricht Microdosing Research Programme was set up to study the effects of LSD microdosing on humans, with a particular focus on mood, cognitive functions, and pain management. The first study, exploring the dose-response relationship in LSD-induced physiological and psychological effects, saw twenty-four healthy volunteers each receive single doses of 5, 10 and 20 micrograms of LSD, or a placebo.
Results clearly demonstrate, for the first time in a controlled and rigorous way, the positive effects of microdosing on mood, cognition and pain management.
Psilocybin for Depression
Type of publication